These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 32698898)

  • 1. Mesenchymal stem cells: current clinical progress in ARDS and COVID-19.
    Xiao K; Hou F; Huang X; Li B; Qian ZR; Xie L
    Stem Cell Res Ther; 2020 Jul; 11(1):305. PubMed ID: 32698898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential.
    Khoury M; Rocco PRM; Phinney DG; Krampera M; Martin I; Viswanathan S; Nolta JA; LeBlanc K; Galipeau J; Weiss DJ
    Cytotherapy; 2020 Nov; 22(11):602-605. PubMed ID: 32933835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
    Al-Khawaga S; Abdelalim EM
    Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome.
    Qu W; Wang Z; Hare JM; Bu G; Mallea JM; Pascual JM; Caplan AI; Kurtzberg J; Zubair AC; Kubrova E; Engelberg-Cook E; Nayfeh T; Shah VP; Hill JC; Wolf ME; Prokop LJ; Murad MH; Sanfilippo FP
    Stem Cells Transl Med; 2020 Sep; 9(9):1007-1022. PubMed ID: 32472653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics.
    Qin H; Zhao A
    Protein Cell; 2020 Oct; 11(10):707-722. PubMed ID: 32519302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of Stem Cell Therapy for Acute Respiratory Distress Syndrome with Focus on COVID 19.
    Kaye RJ
    Pain Physician; 2020 Aug; 23(4S):S421-S432. PubMed ID: 32942797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19.
    Khoury M; Cuenca J; Cruz FF; Figueroa FE; Rocco PRM; Weiss DJ
    Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32265310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS.
    Xu Z; Huang Y; Zhou J; Deng X; He W; Liu X; Li Y; Zhong N; Sang L
    Front Immunol; 2021; 12():738697. PubMed ID: 34659231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weathering the Cytokine Storm in COVID-19: Therapeutic Implications.
    Iannaccone G; Scacciavillani R; Del Buono MG; Camilli M; Ronco C; Lavie CJ; Abbate A; Crea F; Massetti M; Aspromonte N
    Cardiorenal Med; 2020; 10(5):277-287. PubMed ID: 32599589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients.
    Rogers CJ; Harman RJ; Bunnell BA; Schreiber MA; Xiang C; Wang FS; Santidrian AF; Minev BR
    J Transl Med; 2020 May; 18(1):203. PubMed ID: 32423449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for the Use of Radiation-Activated Mesenchymal Stromal/Stem Cells in Acute Respiratory Distress Syndrome.
    Tovar I; Guerrero R; López-Peñalver JJ; Expósito J; Ruiz de Almodóvar JM
    Cells; 2020 Sep; 9(9):. PubMed ID: 32887260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Promise of Mesenchymal Stem Cells Therapy for Acute Respiratory Distress Syndrome Caused by COVID-19.
    Gu J; Zhao Q; Han Z; Han Z
    Curr Stem Cell Res Ther; 2021; 16(3):277-285. PubMed ID: 32729428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of mesenchymal stromal cells in the treatment of coronavirus disease 2019.
    Canham MA; Campbell JDM; Mountford JC
    J Transl Med; 2020 Sep; 18(1):359. PubMed ID: 32958009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect.
    Can A; Coskun H
    Stem Cells Transl Med; 2020 Nov; 9(11):1287-1302. PubMed ID: 32779878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MSCs transplantation may be a potential therapeutic strategy for COVID-19 treatment.
    Wang XY
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4537-4538. PubMed ID: 32373992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular vesicles from mesenchymal stem cells as a Covid-19 treatment.
    O'Driscoll L
    Drug Discov Today; 2020 Jul; 25(7):1124-1125. PubMed ID: 32387262
    [No Abstract]   [Full Text] [Related]  

  • 17. Stem Cell-Based Therapy for Coronavirus Disease 2019.
    Zhao RC
    Stem Cells Dev; 2020 Jun; 29(11):679-681. PubMed ID: 32292113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID-19 ARDS.
    Gibson PG; Qin L; Puah SH
    Med J Aust; 2020 Jul; 213(2):54-56.e1. PubMed ID: 32572965
    [No Abstract]   [Full Text] [Related]  

  • 19. Mesenchymal stem cells as a potential therapy for COVID-19.
    Liu S; Peng D; Qiu H; Yang K; Fu Z; Zou L
    Stem Cell Res Ther; 2020 May; 11(1):169. PubMed ID: 32366290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential.
    Gorman E; Millar J; McAuley D; O'Kane C
    Expert Rev Respir Med; 2021 Mar; 15(3):301-324. PubMed ID: 33172313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.